The acquisition will enable BAL to leverage SFCL#39;s proficiency in developing cost-effective and distinctive manufacturing routes for off-patent molecules, it said.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Leave a Comment